Godavari Biorefineries shares rose as much as 14.8% after the company said a US patent for compounds intended to treat cancer had been granted. Trading volume surged to more than 132 times its weekly average. The patent’s commercial potential and financial contribution remain unclear.
Read more at livemint.com
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.